Palmar plantar erythrodysesthesia secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{ | {{Xyz}} | ||
{{CMG}}; {{AE}} {{MC}} | |||
==Overview== | |||
There are no established measures for the [[Prevention (medical)|secondary prevention]] of palmar plantar erythrodysesthesia. | |||
==Secondary Prevention== | |||
There are no established measures for the [[Prevention (medical)|secondary prevention]] of palmar plantar erythrodysesthesia. | |||
==References== | ==References== | ||
Line 9: | Line 14: | ||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] |
Latest revision as of 20:01, 8 August 2019
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Palmar plantar erythrodysesthesia secondary prevention On the Web |
American Roentgen Ray Society Images of Palmar plantar erythrodysesthesia secondary prevention |
FDA on Palmar plantar erythrodysesthesia secondary prevention |
CDC on Palmar plantar erythrodysesthesia secondary prevention |
Palmar plantar erythrodysesthesia secondary prevention in the news |
Blogs on Palmar plantar erythrodysesthesia secondary prevention |
Risk calculators and risk factors for Palmar plantar erythrodysesthesia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
There are no established measures for the secondary prevention of palmar plantar erythrodysesthesia.
Secondary Prevention
There are no established measures for the secondary prevention of palmar plantar erythrodysesthesia.